ARCHIVES

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

This article is from The Cancer Letter archive.

Vol. 33 No. 17 | May 4, 2007

Download PDF Visit The Full Archive

Related Articles

Avastin Loses Indication for Breast Cancer

November 18, 2011

OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds

April 22, 1983

Orphan Designation Granted To Advaxis HPV Immunotherapy

May 30, 2014

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014